Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses. (2005)


No abstract provided

Bibliographic Information

Digital Object Identifier:

PubMed Identifier: 15117764

Publication URI:

Type: Journal Article/Review

Volume: 105

Parent Publication: Blood

Issue: 1

ISSN: 0006-4971